Benitec Biopharma Inc
F:BJ9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Benitec Biopharma Inc
F:BJ9
|
US |
|
C
|
CENIT AG
XMUN:CSH
|
DE |
|
C
|
Colgate-Palmolive Co
BMV:CL
|
US |
|
P
|
Paccar Inc
DUS:PAE
|
US |
|
D
|
Digital Realty Trust Inc
F:FQI
|
US |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
V
|
Varonis Systems Inc
SWB:VS2
|
US |
|
C
|
Central Garden & Pet Co
F:GP7A
|
US |
|
Dollar Tree Inc
NASDAQ:DLTR
|
US |
|
H
|
HSBC Holdings PLC
F:HBC2
|
UK |
|
E
|
EMX Royalty Corp
XMUN:6E9
|
CA |
|
Siemens AG
F:SIEB
|
DE |
|
Airbus SE
PAR:AIR
|
NL |
|
A
|
Adobe Inc
BMV:ADBE
|
US |
|
S
|
Sino Land Co Ltd
XMUN:SNO
|
HK |
|
D
|
Deutsche Bank AG
BMV:DBN
|
DE |
|
Publicis Groupe SA
F:PU41
|
FR |
|
UniCredit SpA
F:CRIN
|
IT |
|
N
|
Ninety One Ltd
F:L91
|
ZA |
|
V
|
Volkswagen AG
PSE:VOW
|
DE |
|
T
|
Tokyo Electron Ltd
XBER:TKY
|
JP |
|
A
|
Arrowroot Acquisition Corp
NASDAQ:AILE
|
US |
|
Anheuser-Busch Inbev SA
OTC:BUDFF
|
BE |
|
M
|
Mondelez International Inc
SWB:KTF
|
US |
Bankruptcy Probability
Benitec Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Benitec Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Benitec Biopharma Inc
NASDAQ:BNTC
|
417.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Benitec Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Benitec Biopharma Inc has no debt.
You can find a full breakdown on its Balance Sheet.
